Last reviewed: June 30, 2026

Last updated: June 30, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a glucagon-like peptide-1 receptor agonist originally developed for type 2 diabetes that has demonstrated significant weight loss effects in clinical trials, with patients losing 15-22% of their body weight over 68 weeks. Starting semaglutide for weight management involves a simple process: medical evaluation, prescription, and a gradual dose escalation protocol designed to minimize side effects while maximizing results. PlexusDx makes this process accessible across all 50 states without insurance requirements.

Understanding Semaglutide and How It Promotes Weight Loss

Semaglutide works by mimicking a natural hormone called GLP-1 that regulates blood sugar and appetite. When you inject semaglutide, it signals your brain to reduce hunger, increase feelings of fullness after eating, and slow gastric emptying—the rate at which food leaves your stomach. This combination of effects leads to reduced calorie intake without requiring willpower-based restriction.

The medication targets three key pathways: appetite suppression in the hypothalamus, improved insulin secretion, and decreased glucagon release. Research shows that patients on semaglutide eat approximately 400-500 fewer calories per day naturally, without conscious dieting. Results typically become noticeable within 2-4 weeks of starting therapy, with maximum benefit achieved over 12-16 weeks of consistent dosing.

Clinical studies from the STEP trial program demonstrated that patients achieved weight loss plateaus around 16-18 weeks, with continued gradual loss possible with dose optimization. PlexusDx offers both injectable and oral semaglutide formulations to match patient preferences and absorption needs.

Eligibility and Medical Evaluation for Semaglutide Therapy

PlexusDx evaluates candidates based on BMI, metabolic health history, and medication interactions rather than diagnosis alone. While semaglutide was originally approved for diabetes, it is now prescribed off-label for weight loss in patients with a BMI over 27 and existing weight-related health conditions, or BMI over 30 regardless of comorbidities. Your initial consultation includes a blood pressure check, baseline weight measurement, and review of your medical history and current medications.

Certain conditions require extra caution or may contraindicate semaglutide use: personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2, pregnancy or plans to become pregnant within three months, severe kidney disease, or active diabetic retinopathy. PlexusDx clinicians screen for these through a detailed intake process conducted via secure telehealth, ensuring safe candidacy before prescription.

Patients with type 2 diabetes on semaglutide may require insulin dose reduction to prevent hypoglycemia, and those taking other appetite-suppressing medications should discontinue them first. A full medication reconciliation happens during your medical evaluation to prevent dangerous interactions.

The Semaglutide Dose Escalation Protocol and Injection Schedule

PlexusDx follows a gradual dose escalation schedule starting at 0.25 mg once weekly, increasing by 0.25 mg increments every four weeks until reaching your therapeutic dose, typically 1.0-2.4 mg weekly. This slow titration approach significantly reduces nausea, vomiting, and gastrointestinal side effects that can occur with faster increases. Your dose may need to go up. Your price won't—PlexusDx charges a flat monthly rate regardless of your injection strength.

Patients inject semaglutide subcutaneously (under the skin) once per week using a prefilled pen or needle syringe, typically on the same day each week. Common injection sites include the abdomen, thigh, or upper arm. You can rotate sites to minimize lipohypertrophy (localized fat accumulation), and most patients report injections are virtually painless given the fine needle gauge.

The four-week spacing between dose increases allows your body to adapt and your appetite-suppressing effects to stabilize at each level. Some patients achieve weight loss goals at 0.5-1.0 mg weekly, while others benefit from the full 2.4 mg dose. PlexusDx clinicians monitor your progress through monthly check-ins via telehealth to assess tolerability and adjust dosing as needed.

Getting Started with PlexusDx: Access, Cost, and Next Steps

PlexusDx makes semaglutide accessible by connecting you directly with licensed 503A compounding pharmacies that manufacture pharmaceutical-grade semaglutide without insurance requirements. Compounded semaglutide injection starts at $149 per month across all 50 states, with pricing remaining flat regardless of your dose level. Your medications are shipped directly to your home with full clinical support.

To begin, complete a brief online medical questionnaire, then schedule a telehealth consultation with a PlexusDx clinician (no waiting lists). During your visit, the clinician reviews your health history, performs a cardiovascular assessment, and determines semaglutide candidacy. If approved, your prescription is sent to a licensed compounding pharmacy, and your first shipment arrives within 5-7 business days with injection supplies and detailed administration instructions.

PlexusDx accepts HSA and FSA funds for all medications, and no membership fees apply. After your first month of treatment, you may choose to add the Precision Peptide Genetic Test ($99 add-on) to identify genetic variants affecting peptide pathways—specifically markers like GLP1R rs6923761 and GIPR rs1800437 that predict medication response. Ongoing monthly support includes dose adjustments, side effect management, and progress tracking at no additional charge.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How quickly will I see weight loss results from semaglutide?

Most patients notice reduced appetite within 1-2 weeks of starting, with measurable weight loss typically appearing by week 3-4. Significant weight loss momentum builds between weeks 8-16 as your body adjusts to the medication and your dose increases. Individual results vary based on diet, exercise, and genetic factors that PlexusDx's Precision Peptide Genetic Test can help identify.

What side effects should I expect when starting semaglutide?

Common side effects during dose escalation include mild nausea (most frequent in the first 2 weeks), constipation, and occasional diarrhea. These typically resolve within 3-5 days at each dose level and are significantly reduced by the gradual titration protocol PlexusDx uses. Serious side effects are rare in screened candidates, but patients should report persistent vomiting, signs of pancreatitis, or severe abdominal pain immediately.

Is compounded semaglutide from PlexusDx as effective as brand-name Ozempic?

PlexusDx sources compounded semaglutide from licensed 503A compounding pharmacies using pharmaceutical-grade active ingredients formulated to match brand specifications. The compounded versions achieve the same clinical outcomes as brand medications when properly manufactured and dosed, and clinical evidence supports compounded semaglutide efficacy for weight loss. Compounded medications are not FDA-approved but are legal and widely used when sourced from licensed pharmacies.

Can I use my HSA or FSA to pay for PlexusDx semaglutide?

Yes—PlexusDx medications and telehealth consultations are fully HSA/FSA eligible, allowing you to use tax-advantaged health savings accounts to pay for treatment. This can reduce your out-of-pocket costs significantly. No insurance is required, and semaglutide injection starts at $149 per month with flat pricing across all dose levels.

What does the PlexusDx Precision Peptide Genetic Test reveal about semaglutide response?

The Precision Peptide Genetic Test ($99 add-on) maps 14 pathways and identifies variants in your GLP1R, GIPR, FTO, and MC4R genes that influence how your body responds to semaglutide and other GLP-1 medications. For example, specific variants in GLP1R rs6923761 affect receptor sensitivity, helping your PlexusDx clinician predict whether you'll respond best to semaglutide, tirzepatide, or combination therapy. This personalization increases your likelihood of achieving optimal weight loss at your lowest effective dose.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves